Today's Information |
Provided by: SYNMOSA BIOPHARMA CORPORATION | |||||
SEQ_NO | 2 | Date of announcement | 2022/06/22 | Time of announcement | 16:35:37 |
Subject | SYNMOSA announces the record date for 2021 dividend through retained earning. | ||||
Date of events | 2022/06/22 | To which item it meets | paragraph 14 | ||
Statement | 1.Date of the resolution by the board of directors or shareholders' meeting, or of the decision by the company:2022/06/22 2.Type (ex-rights or ex-dividend) (please write "Ex-rights", "Ex-dividend", or "Ex-rights and dividend"):Ex-rights and dividend 3.Type and monetary amount of dividend distribution: Cash dividends NT$150,162,802 ( NT$ 0.50702378 per share) Stock dividends:NT$300,165,200 (NT$1.0135059 per share) 4.Ex-rights (Ex-dividend) date:2022/07/11 5.Last date before book closure:2022/07/12 6.Book closure starting date:2022/07/13 7.Book closure ending date:2022/07/17 8.Ex-rights (Ex-dividend) record date:2022/07/17 9.Deadline for applying the conversion of the debt voucher:NA 10.The closure period for the conversion of the debt voucher will start from the date:NA 11.The closure period for the conversion of the debt voucher will end on the date:NA 12.Payment date of cash dividend distribution:2022/08/15 13.Any other matters that need to be specified: The proposal to issue new shares for capital increase from earnings was Approved by the Financial Supervisory Commission on JUNE 17, 2022 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Synmosa Biopharma Corporation published this content on 22 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 June 2022 08:44:04 UTC.